-
23NovemberStaff and students from Francis Holland School Regent’s Park put on fancy dress and took part in a sponsored walk around Regent’s Park to raise money for Secondary1st. The weather was ideal to enjoy an autumn afternoon in the open … Continue reading
-
31OctoberIn recently published draft guidance NICE has approved the routine use of another drug combination for some people with secondary breast cancer. Palbociclib, also known as Ibrance, is a targeted drug made by Pfizer and is now recommended in combination … Continue reading
-
31OctoberRuth and Stu are preparing to fly to Nepal where they will take part in a 22-day expedition to the summit of Imja Tse, the Nepalese name of Island Peak. Imja Tse is 6200 metres high and is in the … Continue reading
-
02SeptemberPaul will be running the London Marathon on 2nd October to raise money for Secondary1st in memory of his sister-in-law Poppy. He has been training hard through the summer heat and completed an 18-mile run during the Bank Holiday weekend. … Continue reading
-
17AugustCatherine did it and more! She walked the length of Hadrian’s Wall and then walked on for another seventeen miles to raise money for Secondary1st. She crossed the country from Wallsend near Newcastle to Bowness-on-Solway near Carlisle keeping any prevailing … Continue reading
-
27JulyCatherine has spent weeks and weeks preparing for August 2nd when she will set off to walk the 100km length of Hadrian’s Wall east to west across the north of England from Wallsend to Bowness-on-Solway. She hopes to mark the … Continue reading
-
27JulyFinal draft guidance from NICE now recommends that two drugs to treat two different types of secondary or metastatic breast cancer be made available through the Cancer Drugs Fund. Piqray or alpelisib is a kinase inhibitor made by Novartis Pharmaceuticals … Continue reading
-
09JuneOn 2nd August Catherine will set off from Wallsend, Newcastle-Upon-Tyne, to walk the length of Hadrian’s Wall to Bowness-on-Solway in Cumbria. She hopes to complete the 100km distance from coast to coast across Northern England in eight days to raise … Continue reading
-
09JuneResults of a trial of Enhertu (trastuzumab deruxtecan) were presented at the 2022 meeting of the American Society of Clinical Oncology and published in the New England Journal of Medicine. Enhertu is a specifically engineered HER2-directed antibody drug conjugate which … Continue reading
-
09MayOn Sunday May 22nd, Carol will be riding the world’s fastest zip line in memory of her daughter, Nic. She will be joined on the zipline by Nolan and Ian and they will each reach speeds in excess of 100mph. … Continue reading
